<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6657620\results\search\country\results.xml">
  <result pre="Salud PublicaCuernavacaMexico Edited by: Luis F. Garcia, University of Antioquia," exact="Colombia" post="Reviewed by: Florian Krammer, Icahn School of Medicine at"/>
  <result pre="by: Florian Krammer, Icahn School of Medicine at Mount Sinai," exact="United States;" post="Elisa Vicenzi, San Raffaele Hospital (IRCCS), Italy *Correspondence: Herbey"/>
  <result pre="Mount Sinai, United States; Elisa Vicenzi, San Raffaele Hospital (IRCCS)," exact="Italy" post="*Correspondence: Herbey O. Padilla-Quirarte herbey_oswaldo@hotmail.com Fernando Esquivel-Guadarrama fernando.esquivel@uaem.mx This"/>
  <result pre="mAb CH65 was isolated from an adult resident of the" exact="United States" post="that had received the 2007 TIV. According to crystallographic"/>
  <result pre="the anti-NA Abs to the protection process was the 1968" exact="Hong Kong" post="IAV pandemic, during which a new virus (H3N2) emerged."/>
  <result pre="≥40 is taken as protective by the FDA in the" exact="United States" post="(71). Nonetheless and despite the lack of data regarding"/>
  <result pre="patients infected during the 2003 H7N7 outbreak occurred in The" exact="Netherlands" post="(115). Moreover, the presence of Abs against the PB1-F2"/>
  <result pre="Dis. (2010) 202:1634–8. 10.1086/65708420979454 70.MontoASKendalAP. Effect of neuraminidase antibody on" exact="Hong Kong" post="influenza. Lancet. (1973) 1:623–5. 10.1016/S0140-6736(73)92196-X4121842 71.CoxRJ. Correlates of protection"/>
 </snippets>
</snippetsTree>
